Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

Journal of Virology

Volumn 76, Issue 1, 2002, Pages 185-194

  Casimiro, D R ^a   Tang, A ^a   Perry, H C ^a   Long, R S ^a   Chen, M ^a   Heidecker, G J ^a   Davies, M E ^a   Freed, D C ^a   Persaud, N V ^a   Dubey, S ^a   Smith, J G ^a   Havlir, D ^a   Richman, D ^a   Chastain, M A ^a   Simon, A J ^a   Fu, T M ^a   Emini, E A ^a   Shiver, J W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTEGRASE; RNA DIRECTED DNA POLYMERASE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CODON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; MACACA; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURAL GENE; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; GENES, POL; HIV-1; HUMANS; IMMUNIZATION; MACACA MULATTA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0036132824     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.1.185-194.2002     Document Type: Article

References (46)

1. Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees
2. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
3. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIVmac251: Dependence on route of challenge exposure
4. + T cell epitopes: A peptide-based multiparametric assessment in the mouse
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
6. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
7. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector
8. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
9. Intra-and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody
10. Crystal structure of ribonuclease H of HIV-1 reverse transcriptase
11. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary, cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection
12. +cytotoxic T lymphocyte responses in seronegative volunteers
13. Consensus motifs and peptide ligands of MHC class I molecules
14. Total synthesis of a gene for bovine rhodopsin
15. HIV-1: Fifteen proteins and an RNA
16. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope
17. Evaluation of cytotoxic T-lymphocyte responses in human and non-human primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus
18. + T cells in HIV-infected progressors and long-term nonprogressors
19. Functionally inert HIV-specific cytotoxic T lymphcytes do not play a major role in chronically infected adults and children
20. Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease
21. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
22. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
23. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes
24. Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of gag and pol expression
25. Temporal association of cellular immune responses with the initial control of viremia in primary, human immunodeficiency type 1 syndrome
26. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
27. ELISPOT assay for detection of peptide specific interferon-γ secreting cells in rhesus macaques
28. Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations
29. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV gag, pol, env, and nef proteins
30. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences
31. Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: Tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85
32. Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase
33. + T cells using an ELISPOT assay
34. Peptide size selection by the major histocompatibility complex-encoded peptide transporter
35. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
36. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors
37. + lymphocytes
38. Immunization with a modified vaccinia virus expressing simian immunodeficiency (S1V) gag-pol primes for an anamnestic gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
39. Immune responses to HIV gp120 elicited by DNA vaccination
40. Humoral and cellular immunities elicited by HIV-1 DNA vaccination
41. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge
42. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells